Literature DB >> 27001015

Prostate cancer: Validating early PSA response to enable improved treatment decisions.

Clemens Thoma.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27001015     DOI: 10.1038/nrurol.2016.59

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer.

Authors:  Pasquale Rescigno; David Lorente; Diletta Bianchini; Roberta Ferraldeschi; Michael P Kolinsky; Spyridon Sideris; Zafeiris Zafeiriou; Semini Sumanasuriya; Alan D Smith; Niven Mehra; Anuradha Jayaram; Raquel Perez-Lopez; Joaquin Mateo; Chris Parker; David P Dearnaley; Nina Tunariu; Alison Reid; Gerhardt Attard; Johann S de Bono
Journal:  Eur Urol       Date:  2016-03-07       Impact factor: 20.096

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.